URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jeanne Holden-Wiltse

Concepts (120)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
HIV Infections
7
1996
600
0.410
Why?
Anti-HIV Agents
6
1996
179
0.410
Why?
Influenza A Virus, H3N2 Subtype
3
2007
64
0.390
Why?
HIV-1
6
1996
544
0.350
Why?
Orthomyxoviridae Infections
2
2010
99
0.330
Why?
Hemagglutinin Glycoproteins, Influenza Virus
2
2007
43
0.310
Why?
Food Preferences
2
1992
9
0.260
Why?
Influenza Vaccines
2
2007
239
0.260
Why?
HIV Protease Inhibitors
2
1997
56
0.240
Why?
Taste
1
1992
17
0.210
Why?
Obesity
2
1992
301
0.200
Why?
Body Weight
1
1992
328
0.190
Why?
HIV Protease
1
2010
22
0.180
Why?
Spleen
1
2011
338
0.170
Why?
Drug Resistance, Viral
1
2010
67
0.170
Why?
Virus Replication
2
1997
287
0.170
Why?
Delavirdine
2
1999
14
0.170
Why?
Lymphocyte Subsets
1
2009
28
0.170
Why?
Blood
1
2009
92
0.170
Why?
AIDS-Related Opportunistic Infections
2
1998
54
0.170
Why?
CD8-Positive T-Lymphocytes
1
2011
223
0.170
Why?
Cell Movement
1
2011
352
0.160
Why?
Influenza A virus
1
2009
222
0.140
Why?
Influenza, Human
1
2009
329
0.130
Why?
B-Lymphocytes
1
2009
460
0.130
Why?
Adult
13
1992
10906
0.120
Why?
RNA, Viral
6
1996
274
0.100
Why?
Female
13
1992
19061
0.100
Why?
HIV Reverse Transcriptase
2
1998
110
0.100
Why?
Antiviral Agents
2
1996
181
0.100
Why?
Antiprotozoal Agents
1
2001
1
0.100
Why?
Pyrimethamine
1
2001
5
0.100
Why?
Toxoplasmosis
1
2001
6
0.100
Why?
Reverse Transcriptase Inhibitors
2
1998
87
0.090
Why?
Middle Aged
9
1992
9461
0.090
Why?
CD4 Lymphocyte Count
5
1996
147
0.090
Why?
Azithromycin
1
2001
19
0.090
Why?
Mice, Inbred C57BL
3
2009
1613
0.090
Why?
Encephalitis
1
2001
55
0.090
Why?
Humans
15
1992
35000
0.080
Why?
Perylene
1
1999
1
0.080
Why?
Male
12
1992
18870
0.080
Why?
Sarcoma, Kaposi
1
1998
15
0.080
Why?
Models, Theoretical
2
2009
190
0.080
Why?
Sesquiterpenes
1
1998
19
0.080
Why?
Piperazines
1
1998
71
0.070
Why?
Antibiotics, Antineoplastic
1
1998
51
0.070
Why?
Acquired Immunodeficiency Syndrome
1
1999
207
0.070
Why?
Urea
1
1997
51
0.070
Why?
Didanosine
1
1996
21
0.070
Why?
Anti-Bacterial Agents
1
2001
432
0.070
Why?
Ribavirin
1
1996
45
0.070
Why?
Half-Life
2
1998
98
0.060
Why?
Skin Neoplasms
1
1998
225
0.060
Why?
Mice
3
2009
5900
0.060
Why?
Mutation
1
2000
1183
0.060
Why?
Lung
2
2009
1132
0.050
Why?
Drug Therapy, Combination
3
1996
375
0.050
Why?
Dietary Carbohydrates
1
1992
53
0.050
Why?
Dose-Response Relationship, Drug
3
1998
1085
0.050
Why?
Dietary Fats
1
1992
55
0.050
Why?
Animals
4
2001
15647
0.050
Why?
Models, Immunological
1
2011
62
0.050
Why?
Adolescent
2
1992
4513
0.050
Why?
Virology
1
2010
22
0.040
Why?
Virulence
1
2010
152
0.040
Why?
Immunoglobulin M
1
2010
146
0.040
Why?
Lymph Nodes
1
2011
207
0.040
Why?
Hong Kong
1
2009
23
0.040
Why?
Cross Reactions
1
2009
110
0.040
Why?
Lymphocyte Activation
1
2011
407
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2010
130
0.040
Why?
Drug Resistance, Microbial
2
1998
115
0.040
Why?
HIV Core Protein p24
2
1998
28
0.040
Why?
Immunologic Memory
1
2009
132
0.040
Why?
Viral Load
2
1998
138
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
459
0.040
Why?
Immunoglobulin G
1
2010
491
0.040
Why?
Epithelial Cells
1
2010
324
0.040
Why?
Antibodies, Viral
1
2010
472
0.040
Why?
Immunodiffusion
1
2007
41
0.040
Why?
Disease Models, Animal
1
2011
908
0.040
Why?
Hemagglutination Inhibition Tests
1
2007
74
0.040
Why?
Vaccines, DNA
1
2007
22
0.040
Why?
Baculoviridae
1
2007
43
0.040
Why?
Predictive Value of Tests
1
2009
579
0.040
Why?
Computer Simulation
1
2009
295
0.040
Why?
Drug Administration Schedule
2
1997
362
0.030
Why?
Influenza B virus
1
2007
43
0.030
Why?
Cohort Studies
2
1998
912
0.030
Why?
Influenza A Virus, H1N1 Subtype
1
2007
85
0.030
Why?
Double-Blind Method
1
2007
985
0.030
Why?
Child
1
1992
3897
0.030
Why?
Models, Biological
1
2009
982
0.030
Why?
Time Factors
1
2010
3047
0.030
Why?
Toxoplasma
1
2001
4
0.020
Why?
Dermatitis, Phototoxic
1
1999
4
0.020
Why?
Injections, Intravenous
1
1999
125
0.020
Why?
Drug Eruptions
1
1998
28
0.020
Why?
Administration, Oral
1
1999
302
0.020
Why?
Statistics, Nonparametric
1
1999
251
0.020
Why?
Cyclohexanes
1
1998
17
0.020
Why?
Zalcitabine
1
1997
6
0.020
Why?
Area Under Curve
1
1998
61
0.020
Why?
Leukocytes, Mononuclear
1
1998
109
0.020
Why?
Injections, Subcutaneous
1
1997
89
0.020
Why?
Zidovudine
1
1997
69
0.020
Why?
Interferon-alpha
1
1997
84
0.020
Why?
Giant Cells
1
1996
11
0.020
Why?
Viremia
1
1996
26
0.020
Why?
Drug Interactions
1
1996
176
0.020
Why?
Genetic Variation
1
1996
148
0.020
Why?
Recombinant Proteins
1
1997
706
0.020
Why?
Molecular Sequence Data
1
2000
1993
0.020
Why?
Follow-Up Studies
1
1999
1757
0.010
Why?
Treatment Outcome
1
2001
2487
0.010
Why?
United States
1
2001
2511
0.010
Why?
Dietary Proteins
1
1992
27
0.010
Why?
Cells, Cultured
1
1998
2367
0.010
Why?
Food
1
1992
31
0.010
Why?

Visualizations


Holden-Wiltse's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department